Correlation of increase in phosphene threshold with reduction of migraine frequency: Observation of levetiracetam-treated subjects

Headache

Volumn 48, Issue 10, 2008, Pages 1490-1498

  Young, William ^a   Shaw, James ^b   Bloom, Melissa ^a   Gebeline Myers, Cheryl ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Levetiracetam; Migraine prophylaxis; Migraine with aura; Migraine without aura; Phosphene threshold; Transcranial magnetic stimulation

Indexed keywords

ETIRACETAM;

ADULT; AMNESIA; ARTICLE; BALANCE DISORDER; BODY MASS; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG DOSE TITRATION; FATIGUE; FEMALE; HUMAN; INSOMNIA; IRRITABILITY; LEARNING; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL INSTABILITY; MIGRAINE; MUSCLE CRAMP; NAUSEA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RACE; SIDE EFFECT; SOMNOLENCE; TENSION HEADACHE; TRANSCRANIAL MAGNETIC STIMULATION; VISION; VISUAL CORTEX;

ADULT; ANTICONVULSANTS; CAUSALITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROMAGNETIC FIELDS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE WITH AURA; OBESITY; PHOSPHENES; PIRACETAM; SENSORY THRESHOLDS; TENSION-TYPE HEADACHE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; VISUAL CORTEX;

EID: 56549110297     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01292.x     Document Type: Article

References (16)

1. Rapoport AM, Sheftell FD, Tepper SJ, Bigal ME. Levetiracetam in the preventive treatment of transformed migraine: A prospective, open-label, pilot study. Curr Ther Res Clin Exp. 2005 66 : 212 221.
2. Cochran JW. Levetiracetam as migraine prophylaxis. Clin J Pain. 2004 20 : 198 199.
3. Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache. 2004 44 : 238 243.
4. Gallai V, Alberti A, Rossi C, et al. An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine. J Headache Pain. 2003 4 : 92 96.
5. Margineanu DG, Klitgaard H. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res. 2000 42 : 281 285.
6. de TM, Marinazzo D, Nitti L, et al. Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine. Clin Neurophysiol. 2007 118 : 2297 2304.
7. Lang E, Kaltenhauser M, Neundorfer B, Seidler S. Hyperexcitability of the primary somatosensory cortex in migraine - a magnetoencephalographic study. Brain. 2004 127 : 2459 2469.
8. Welch KM. Brain hyperexcitability: The basis for antiepileptic drugs in migraine prevention. Headache. 2005 45 (Suppl. 1 S25 S32.
9. Werhahn KJ, Wiseman K, Herzog J, Forderreuther S, Dichgans M, Straube A. Motor cortex excitability in patients with migraine with aura and hemiplegic migraine. Cephalalgia. 2000 20 : 45 50.
10. Battelli L, Black KR, Wray SH. Transcranial magnetic stimulation of visual area V5 in migraine. Neurology. 2002 58 : 1066 1069.
11. Young WB, Oshinsky ML, Shechter AL, Gebeline-Myers C, Bradley KC, Wassermann EM. Consecutive transcranial magnetic stimulation: Phosphene thresholds in migraineurs and controls. Headache. 2004 44 : 131 135.
12. Aurora SK, Ahmad BK, Welch KM, Bhardhwaj P, Ramadan NM. Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology. 1998 50 : 1111 1114.
13. Headache Classification Committee. The international classification of headache disorders, 2nd Edition. Cephalalgia. 2004 24 : 1 160.
14. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol. 2006 59 : 652 661.
15. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and chronic migraine: Possible mechanisms of interaction. Neurology. 2007 68 : 1851 1861.
16. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001 41 : 646 657.